Talk to the Institute
Published mark

C4 Therapeutics, Inc.

NASDAQ: CCCC. Canonical company identity and public leadership record.

US

Record source reportedRecord not claimedNo Eval published
Follow companySave PDF
Alpha ID
alpha:company:fccbee49-deff-4b94-b996-365c6fc44629
SEC CIK
0001662579
Record version
vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce, published Oct 16, 2026
Newest evidence
Apr 29, 2026
Monitoring
Not yet monitored Details
Integrity
Not yet signed Methodology
CEO
Andrew HirschSince Apr 29, 2026
Chair
Not published
Independent
8 / 99 directors published
Published claims
253 distinct sources
Evidence records
60 pinned
Source conflicts
0None open

Built from 3 distinct sources and 6 evidence records. Every Claim links to where it appears. Where nothing was published, the record states the coverage gap.

CorroboratedSource reportedAlpha inferenceNot disclosed

Public record. Alpha publishes governance facts about this organization from regulatory filings and company statements. Private enterprise overlay data is never projected here. The company can claim the record, correct, or dispute any Claim. How this works

CEO CHANGED

Andrew Hirsch executive of C4 Therapeutics, Inc., effective 2026-04-29.

EffectiveEffective Apr 29, 2026E3

Monitoring

Continuous

What the published record states about identity, evidence, evaluation, monitoring, authority, and freshness. Watched-source schedules are not published for this record.

  • Identityunclaimed
    Published
  • Evidencesource_reported
    Published
  • Evaluationnot_evaluated
    Published
  • MonitoringNot yet published for this record.
    Not published
  • AuthorityNot yet published for this record.
    Not published
  • Freshnesscurrent
    Published

Leadership

Evidence
RolePersonSinceStatusClaim
President and Chief Executive OfficerAndrew HirschApr 2026currentSource reportedE3
Chief Financial Officer, Head of Corporate AffairsKendra R. AdamsApr 2026currentSource reportedE4
Chief Medical OfficerLeonard Reyno, M.D.Apr 2026currentSource reportedE5

Board of directors

Evidence

9 directors published. 8 of 9 with a published determination are independent.

DirectorStatusSinceCommitteesClaim
Andrew HirschNot independent2020None publishedSource reportedE2
Donna Grogan, M.D.Independent2022None publishedSource reportedE2
Kenneth C. Anderson, M.D.Independent2015None publishedSource reportedE2
Laura Bessen, M.D.Independent2022None publishedSource reportedE2
Owen HughesIndependent2023AuditSource reportedE2
Ronald Harold Wilfred CooperIndependent2024Nominating and Governance, chairNominating and Governance · ChairSource reportedE2
Stephen Fawell, Ph.D.Independent2024None publishedSource reportedE2
Steven HoerterIndependent2024AuditAudit; Compensation · ChairCompensation, chairSource reportedE2
Utpal KoppikarIndependent2022Audit, chairAudit · Chair; CompensationCompensationSource reportedE2

Committees and risk ownership

Evidence
CommitteeChairMembersRisks assigned
AuditUtpal KoppikarUtpal Koppikar, Owen Hughes, Steven HoerterNot described in the published record
Audit · Chair; CompensationNot publishedUtpal KoppikarNot described in the published record
Audit; Compensation · ChairNot publishedSteven HoerterNot described in the published record
CompensationSteven HoerterSteven Hoerter, Utpal KoppikarNot described in the published record
Nominating and GovernanceRonald Harold Wilfred CooperRonald Harold Wilfred CooperNot described in the published record
Nominating and Governance · ChairNot publishedRonald Harold Wilfred CooperNot described in the published record
Committee RecordAudit: Chair Utpal Koppikar; Members Utpal Koppikar (Chair); Owen Hughes; Steven Hoerter
Source reportedE6
company:fccbee49-deff-4b94-b996-365c6fc44629:committee_record:17
Committee AppointmentUtpal Koppikar: chair, Audit
Source reportedE6
company:fccbee49-deff-4b94-b996-365c6fc44629:committee_appointment:18
Committee AppointmentOwen Hughes: member, Audit
Source reportedE6
company:fccbee49-deff-4b94-b996-365c6fc44629:committee_appointment:19
Committee AppointmentSteven Hoerter: member, Audit
Source reportedE6
company:fccbee49-deff-4b94-b996-365c6fc44629:committee_appointment:20
Committee RecordCompensation: Chair Steven Hoerter; Members Steven Hoerter (Chair); Utpal Koppikar
Source reportedE6
company:fccbee49-deff-4b94-b996-365c6fc44629:committee_record:21
Committee AppointmentSteven Hoerter: chair, Compensation
Source reportedE6
company:fccbee49-deff-4b94-b996-365c6fc44629:committee_appointment:22
Committee AppointmentUtpal Koppikar: member, Compensation
Source reportedE6
company:fccbee49-deff-4b94-b996-365c6fc44629:committee_appointment:23
Committee RecordNominating and Governance: Chair Ronald Harold Wilfred Cooper; Members Ronald Harold Wilfred Cooper (Chair)
Source reportedE6
company:fccbee49-deff-4b94-b996-365c6fc44629:committee_record:24
Committee AppointmentRonald Harold Wilfred Cooper: chair, Nominating and Governance
Source reportedE6
company:fccbee49-deff-4b94-b996-365c6fc44629:committee_appointment:25

Control and voting power

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Authority to act

Evidence and agent registry

Who can act for the company, and on whose authority. This is what a counterparty's agent checks before it accepts an order, signs, or pays.

Principal executive officerAndrew Hirsch, President and Chief Executive Officer, from Apr 29, 2026
Source reportedE3
company:fccbee49-deff-4b94-b996-365c6fc44629:leadership_role:14
Who can authorize an agentNot assessedNo Alpha inference about signing authority or board-reserved matters is published for this record.
Not assessed
bind
AI agents registered by the companyNot registered in the public RegistryAgent Deployments, Agent Use Cases, Authority Grants, TrustChecks, Action Ledger entries and Governance Receipts live in the private enterprise overlay. They are never projected into the public Registry without explicit cross-plane authorization. Absence here is a plane boundary, not evidence that the enterprise operates no agents.
Agent registry
agents
Delegations publishedNot disclosedBoard and officer delegation resolutions are not public filings and are not published in this record.
Search scope
delegations

Financials and market context

Evidence
Security ListingCCCC (NASDAQ)
Source reportedE1
company:fccbee49-deff-4b94-b996-365c6fc44629:security_listing:26
Index membershipsNo current membership is published in Alpha's tracked index universe.This is not evidence that the company is absent from every market index.
None publishedAs of Oct 16, 2026. Rights-filtered public evidence only; no redistribution or model training is granted. Only source-backed memberships with an explicit public redistribution basis are returned.

Governance and policies

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Risk, audit, and cyber

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

AI oversight and accountability

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Compensation

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Other published claims

Evidence

Published Claims that belong to no section above. Each keeps its permalink, evidence, and assertion state.

Legal NameC4 Therapeutics, Inc.
Source reportedE1
company:fccbee49-deff-4b94-b996-365c6fc44629:legal_name:1
Entity StatusPublic listing published
Source reportedE1
company:fccbee49-deff-4b94-b996-365c6fc44629:entity_status:3

Not yet in this record

Coverage

A gap is a coverage state, not a negative finding. These sections are expected for this entity class and are not yet published.

  • Corporate structureNot reviewed. Parent, subsidiary and predecessor structure explains who is governed.
  • OwnershipNot reviewed. Ownership and voting power determine who can influence the board.
  • FinancialsNot reviewed. Governance-relevant financial context frames capital and audit decisions.
  • CompensationNot reviewed. Pay design shows how incentives are governed.
  • GovernanceNot reviewed. Governing documents and provisions set the rules of the enterprise.
  • Shareholder governanceNot reviewed. Meeting and vote records show shareholder dissent and support.
  • AuditNot reviewed. Auditor, controls and restatements show assurance over reporting.
  • LegalNot reviewed. Material legal and regulatory matters show enforcement exposure.
  • RiskNot reviewed. Risk ownership links the board, committees, executives and controls.
  • CyberNot reviewed. Cyber and data governance is a disclosed oversight domain.
  • AI governanceNot reviewed. AI oversight is a differentiated Alpha governance domain.
  • Markets externalNot reviewed. Auditors, advisors, investors and regulators form the external ecosystem.
  • Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
  • Only explicitly published canonical company identity and current confirmed public roles are included.Only explicitly published canonical company identity and current confirmed public roles are included.
  • Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
  • Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
  • This Company Profile is an identity and evidence record, not an Alpha rating.This Company Profile is an identity and evidence record, not an Alpha rating.

Subject and corrections

Public-role doctrine

This record exists because the company is in the published Registry. The company can claim the record, correct, or dispute any Claim. Corrections are versioned and the original stays in history.

Basis
Published company record built from public sources
Sources
6 evidence records cited. 0 with redistribution rights.
Never published
Private enterprise overlay data: deployments, authority grants, TrustChecks, receipts, telemetry
Record claimed
No
Open disputes
0
Identity ownership
unclaimed
Claiming not yet available

If the company claims the record, its statements appear as their own assertion state and never overwrite the cited evidence.

Evidence

Authority and rights
  1. E1
    Alpha canonical company public projection
    Alpha canonical company public projection. canonical identity. Retrieved Oct 16, 2026. Cited by 4 Claims.
    Open web
    Rights not recorded, link only
    Evidence not pinned
  2. E2
    C4 Therapeutics, Inc. DEF 14A 2025-04-29
    sec proxy. Published Apr 29, 2025. Retrieved Apr 28, 2026. Cited by 9 Claims.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  3. E3
    CCCC DEF 14A executive officers
    sec filing. Published Apr 29, 2026. Retrieved May 16, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  4. E4
    CCCC DEF 14A executive officers
    sec filing. Published Apr 29, 2026. Retrieved May 16, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  5. E5
    CCCC DEF 14A executive officers
    sec filing. Published Apr 29, 2026. Retrieved May 16, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  6. E6
    Audit
    board_seats. board seats. Cited by 9 Claims.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned

What changed in version public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce

vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce published Oct 16, 2026
  • Andrew Hirsch executive of C4 Therapeutics, Inc., effective 2026-04-29.
  • Kendra R. Adams executive of C4 Therapeutics, Inc., effective 2026-04-29.
  • Leonard Reyno, M.D. executive of C4 Therapeutics, Inc., effective 2026-04-29.
  • Ronald Harold Wilfred Cooper seat on C4 Therapeutics, Inc., effective 2024-01-01.
  • Stephen Fawell, Ph.D. seat on C4 Therapeutics, Inc., effective 2024-01-01.
  • Steven Hoerter seat on C4 Therapeutics, Inc., effective 2024-01-01.
  • Audit; Compensation · Chair committee of C4 Therapeutics, Inc., effective 2024-01-01.
  • Steven Hoerter member of Audit; Compensation · Chair, effective 2024-01-01.
  • Nominating and Governance · Chair committee of C4 Therapeutics, Inc., effective 2024-01-01.
  • Ronald Harold Wilfred Cooper member of Nominating and Governance · Chair, effective 2024-01-01.
  • Owen Hughes seat on C4 Therapeutics, Inc., effective 2023-01-01.
  • Owen Hughes member of Audit, effective 2023-01-01.
  • Donna Grogan, M.D. seat on C4 Therapeutics, Inc., effective 2022-01-01.
  • Laura Bessen, M.D. seat on C4 Therapeutics, Inc., effective 2022-01-01.
  • Utpal Koppikar seat on C4 Therapeutics, Inc., effective 2022-01-01.
  • Audit · Chair; Compensation committee of C4 Therapeutics, Inc., effective 2022-01-01.
  • Utpal Koppikar member of Audit · Chair; Compensation, effective 2022-01-01.
  • Andrew Hirsch seat on C4 Therapeutics, Inc., effective 2020-01-01.
  • Kenneth C. Anderson, M.D. seat on C4 Therapeutics, Inc., effective 2015-01-01.
Appearance

Alpha Governance PBC. The Registry records reported facts and Alpha's assessments separately. A missing fact is not evidence that it is false.

Record alpha:company:fccbee49-deff-4b94-b996-365c6fc44629, version public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce. https://registry.alpha.ac/companies/c4-therapeutics-inc

Navigate

On this record

  1. Overview
  2. Monitoring4
  3. Leadership3
  4. Board9
  5. Committees6
  6. Control and voting0
  7. Authority to act4
  8. Financials1
  9. Governance0
  10. Risk0
  11. AI oversight0
  12. Legal0
  13. Compensation0
  14. Other published claims3
  15. Coverage gaps17
  16. Linked people11
  17. Subject and corrections6
  18. Evidence6
  19. Version historyvpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce

Linked records

Registry

Appearance

esc
  • Actions
    Switch to agent viewJSON, Markdown, MCP
  • Copy Alpha IDalpha:company:fccbee49-deff-4b94-b996-365c6fc44629
  • Cite this recordC4 Therapeutics, Inc.
  • Copy canonical URLregistry.alpha.ac/companies/c4-therapeutics-inc
  • Copy as MarkdownWith assertion states
  • Report an error
  • Theme: System
  • Theme: Light
  • Theme: Dark
  • Records
    C4 Therapeutics, Inc.Company
  • Andrew HirschPerson
  • Kendra R. AdamsPerson
  • Leonard Reyno, M.D.Person
  • Donna Grogan, M.D.Person
  • Kenneth C. Anderson, M.D.Person
  • Laura Bessen, M.D.Person
  • Owen HughesPerson
  • Ronald Harold Wilfred CooperPerson
  • Stephen Fawell, Ph.D.Person
  • Steven HoerterPerson
  • Utpal KoppikarPerson
  • Sections
    OverviewC4 Therapeutics, Inc.
  • MonitoringC4 Therapeutics, Inc.
  • LeadershipC4 Therapeutics, Inc.
  • BoardC4 Therapeutics, Inc.
  • CommitteesC4 Therapeutics, Inc.
  • Control and votingC4 Therapeutics, Inc.
  • Authority to actC4 Therapeutics, Inc.
  • FinancialsC4 Therapeutics, Inc.
  • GovernanceC4 Therapeutics, Inc.
  • RiskC4 Therapeutics, Inc.
  • AI oversightC4 Therapeutics, Inc.
  • LegalC4 Therapeutics, Inc.
  • CompensationC4 Therapeutics, Inc.
  • Other published claimsC4 Therapeutics, Inc.
  • Coverage gapsC4 Therapeutics, Inc.
  • Linked peopleC4 Therapeutics, Inc.
  • Subject and correctionsC4 Therapeutics, Inc.
  • EvidenceC4 Therapeutics, Inc.
  • Version historyC4 Therapeutics, Inc.
↑ ↓ move↵ openThis record only

Report an error

Reports attach to the Claim and go to an Alpha analyst through the correction form. Corrections are versioned, and the original stays in history.